Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Filed with HKEX · Stock code 1801 · · 11 pages · English
Summary by 6ix AI
It reports on the movements in authorized and registered share capital, confirming a total authorized share capital at the end of the month. The document also includes details on issued shares, treasury shares, and public float sufficiency confirmation. The filing confirms compliance with applicable public float requirements and provides a summary of share option movements.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Innovent Biologics, Inc. on 6ix
Earlier from Innovent Biologics
- 2026 Interim report
- Voluntary announcement - Jaypirca (pirtobrutinib) approved in China for a new indication in chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) across all lines of therapy
- Innovent Announces Expansion of Global Phase 3 MarsLight-11 Study of IBI363/TAK-928 (Alpha-biased IL-2/PD-1 Bispecific Fusion Protein) in Immunotherapy-Resistant NSCLC to Include Patients with Non-Squamous NSCLC
- Altruist Biologics' Suzhou Site Receives EMA GMP Certification, Enabling Product Commercialization for the European Market
- Innovent Announces 2026 Interim Results and Business Updates
Follow Innovent Biologics into a list and get an email when it puts out news.
Follow Innovent Biologics